Abstract
Streptococcus pneumoniae is an important human pathogen, causing severe diseases such as pneumonia, bacteremia, sepsis and meningitis. The currently available vaccines are based on the response against the capsular polysaccharide, but they have some shortcomings such as high cost and restricted serotype coverage. The development of new vaccines against pneumococcal infections thus remains…